Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Neuromedin C is a bombesin-like neuropeptide that stimulates uterine smooth muscle contraction and the release of gastrin (Item No. 24457), somatostatin, and amylase in rats.1,2 Neuromedin C is a truncated form of gastrin-releasing peptide (GRP; Item Nos. 24415 | 24455) corresponding to the GRP amino acids 18-27. It inhibits GRP and bombesin (Item No. 24151) binding to rat pancreatic membranes (IC50s = 0.4 and 2.2 nM, respectively), which can be reduced by sodium chloride and guanylyl imidodiphosphate (Item No. 16880).2 Neuromedin C induces scratching and mast cell degranulation in mice when administered intradermally at doses ranging from 1 to 300 nmol/site, which is inhibited by the BB2 bombesin receptor agonist RC-3095 and reduced in mast cell-deficient mice.3 Neuromedin C (3.2 nmol/kg, i.p.) reduces rat glucose consumption by approximately 50% for up to one hour.4
WARNING This product is not for human or veterinary use.
1. Effect of gastrin-
2. Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-
3. Gastrin-
4. Blockade of feeding inhibition by neuromedin B using a selective receptor antagonist. Eur. J. Pharmacol. 271(1), R7-R9 (1994).